-
Mashup Score: 14
#1: Model Medicines’ CHEMprint™ AI/ML drug discovery platform discovered MDL-001 and identified that the drug was expected to inhibit SARS-CoV-2 replication via a broad spectrum antiviral target, indicating that MDL-001 may be effective against a broad array of RNA based viruses and SARS-CoV-2 varia
Source: Model MedicinesCategories: General Medicine News, Latest HeadlinesTweet
Scripps Research's #DrugDiscovery division, Calibr, @modelmedicines and @icahnmountsinai used #AI to find compounds with activity against the virus behind the #COVID19 pandemic. https://t.co/KeCK2nVHub